Navigation Links
Amgen Establishes Commercial Operations in Brazil
Date:4/8/2011

THOUSAND OAKS, Calif., April 8, 2011 /PRNewswire/ -- Amgen (NASDAQ: AMGN), the world's largest biotechnology company, announced today the expansion of its operations in Brazil, including the acquisition of Bergamo, a privately-held Brazilian pharmaceutical company. Amgen has also agreed to reacquire rights in Brazil to its products that were previously granted to Mantecorp (subsequently acquired by Hypermarcas). Together, these transactions will provide Amgen a significant presence in Brazil and immediate, direct access to one of the fastest growing pharmaceutical markets in the world.

Bergamo is a leading supplier of medicines to the hospital sector in Brazil with capabilities in oncology medicines and has manufacturing facilities in Sao Paulo state. Bergamo had gross revenues of US $80 million in 2010 and has been growing at an annual rate of 19 percent since 2007. Under terms of the transaction announced today, Amgen gained full ownership of Bergamo by purchasing it for approximately US $215 million.

Amgen has entered into an agreement in principle with Hypermarcas to reacquire the rights in Brazil to several of Amgen's innovative medicines, two of which are already approved in Brazil, Vectibix® (panitumumab) and Mimpara® (cinacalcet), and a third, romiplostim, (registered as Nplate® in the United States), a treatment for the blood disorder ITP, which is currently under review by ANVISA, the regulatory authority in Brazil.

"Amgen's strategic goal is to make our innovative medicines available to patients in major markets around the world," said Kevin Sharer, Amgen's chairman and chief executive officer.  "Acquiring Bergamo, a profitable company with an established local infrastructure, and regaining the rights to our products in Brazil, provides us an attractive entry into the Brazilian market."

The focus on Brazil is part of
'/>"/>

SOURCE Amgen
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Arthritis Foundation Announces Amgen and Wyeth to Be Presenting Sponsor of the 2008 Arthritis Walk (R)
2. Medarex to Receive Milestone Payment from Amgen
3. AMT Obtains License to Amgens GDNF Gene to Develop Treatment for Parkinsons Disease with AMTs Proprietary Gene Therapy Platform
4. Amgen, Takeda and Millennium Provide Update on Phase 3 Trial of Motesanib in Patients With Non-Small Cell Lung Cancer
5. CDC Foundation Partners with Amgen, CDC to Reduce Infections Among Cancer Patients
6. Amgen Announces Positive Top-Line Results for Denosumab in Trial for Delay of Skeletal Related Events in Bone Metastases Patients Compared to Zometa(R)
7. Amgen Issues Statement on Outcomes of Advisory Committee for Reproductive Health Drugs (ACRHD) Meeting
8. Amgen Announces Top-Line Results of Trial to Reduce Cardiovascular Events With Aranesp(R) Therapy (TREAT) in CKD Patients With Type-2 Diabetes
9. Amgen Presents Data From First Nplate(R) Study in Children With Chronic ITP
10. Amgen Highlights Data to be Presented at American Society for Bone and Mineral Research (ASBMR) Meeting
11. Amgen Board Authorizes $5 Billion Increase in Stock Repurchase Program
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/20/2014)... 2014 Norgine B.V. today announced ... volume bowel preparation, NER1006, presented at the 79 th ... Gastroenterology (ACG), Philadelphia, PA , has ... and co-primary endpoint of cleansing success. The study demonstrated ... ® in screening colonoscopy patients. [1] ...
(Date:10/19/2014)... 2014 Große Pharmafirmen werden ... Problem dabei ist, dass große Pharmafirmen nicht willens ... teilen. Es war deshalb nicht einfach, ... umso mehr, dass es uns gelungen ist! Wir ... aufzuschreiben - mit einem Vorbehalt - einige haben ...
(Date:10/17/2014)... 2014  Amgen (NASDAQ: AMGN ) today ... M.D., president of Gladstone Institutes and Gladstone,s Robert W. ... "We are pleased to welcome Dr. Sandy Williams ... Bradway , chairman and chief executive officer of Amgen. ... and his direct experience in our industry will both ...
Breaking Medicine Technology:Positive Results from Phase II Data Show NER1006 Achieves High Quality Bowel Cleansing Efficacy 2Vergleichsbericht zu Pharma-Kühlketten und CRT 2Amgen Announces Appointment Of R. Sanders Williams To Board Of Directors 2Amgen Announces Appointment Of R. Sanders Williams To Board Of Directors 3
... April 12, 2011 Havel,s market leading EchoStim® ... allows practitioners to perform Peripheral Nerve Blocks (PNBs) ... same time.  The new improved needle has more, ... ultrasound easier, giving even inexperienced practitioners the benefits ...
... April 12, 2011 Perrigo (Nasdaq: PRGO ; ... and Drug Administration (FDA) has concluded its re-inspection of Perrigo,s ... the Company has an acceptable regulatory status, such that any ... once again be eligible for review and approval. ...
Cached Medicine Technology:Perrigo Announces Conclusion of the FDA Re-Inspection 2
(Date:10/20/2014)... 20, 2014 Allegheny General Hospital’s (AGH) ... enables physicians to repair a damaged mitral valve as ... system, developed by Abbott Vascular , is ... and life-threatening condition in which the heart’s mitral valve ... backward from the heart’s left ventricle into the left ...
(Date:10/20/2014)... 2014 hc1.com today announced the ... solution that enables healthcare organizations of all sizes ... customer relationship management (“CRM”) solution. , Designed from ... of the healthcare industry, the hc1 Healthcare Relationship ... patients by combining healthcare CRM, HIPAA-compliant collaboration, and ...
(Date:10/20/2014)... AttorneyOne.com, a recognized authority on law, update the ... on Sit and Slim II . , The ... use Sit and Slim II because it contains Sibutramine ... weight loss product on various websites and possibly in some ... for safety reasons, can significantly increase blood pressure and/or pulse ...
(Date:10/20/2014)... 2014 National Teen Driver Safety Week is ... Academy of Pediatrics (Ohio AAP, http://www.ohioaap.org ) is joining ... of teen drivers to talk to their teens and always ... vehicle crashes are the leading cause of death for U.S. ... fatal crashes, and 859 (42%) of those teen drivers were ...
(Date:10/20/2014)... Houston plastic surgeon Dr. Christopher Patronella ... his innovative True Form Tummy Tuck® method ... faculty at The University of Texas Medical Branch ... a medical student. Patronella, who is a founding partner ... practices in Texas, The Aesthetic Center for Plastic ...
Breaking Medicine News(10 mins):Health News:Allegheny General Hospital Introduces New, Beating-Heart Procedure for Mitral Valve Repair 2Health News:Allegheny General Hospital Introduces New, Beating-Heart Procedure for Mitral Valve Repair 3Health News:Healthcare Relationship Management (HRM) Leader hc1.com® Launches hc1® Quick Start™ 2Health News:FDA Advises Not to Use Sit and Slim II: AttorneyOne Monitors and Keeps Consumers Informed 2Health News:Ohio AAP Promotes National Teen Driver Safety Week 2Health News:Plastic Surgeon Patronella Presents Artistically-Inspired Tummy Tuck Method to Future Generation of Plastic Surgeons in Texas 2
... FL, July 6, 2010 Embargoed by the journal ... Scientists from The Scripps Research Institute have found that ... in determining vulnerability to cocaine addiction and may offer an ... animal studies, the scientists found that a molecule called microRNA-212 ...
... of dental care continues to be a significant problem for American ... to dental disease. A new study published in ... that in California, nearly 25 percent of children have never seen ... of insurance when it comes to the duration between dental care ...
... HealthDay Reporter , WEDNESDAY, July 7 (HealthDay News) -- ... is less accurate when done in the summer than in ... Although the particular brand of test used in the study ... United States, the findings are of interest to U.S. researchers ...
... By Steven Reinberg HealthDay Reporter , TUESDAY, July ... or no relief for sufferers of chronic lower back pain ... trial seems to be another knock against glucosamine, with other ... questions: ,I have suffered low back pain for a long ...
... ... of a State-of-the-Art Hospital in Rural Kenya. Founded by a Kaiser Permanente Oncologist, ... Foundation,s Investment Management Approach to African Philanthropy is a Departure from Traditional Grant-making. ... (PRWEB) July ...
... ... outlines considerations when applying for SSDI with spinal cord impairments , ... Belleville, Ill. (Vocus) -- Every 41 ... 11,000 new cases each year, according to the United Spinal Association. Allsup, a nationwide ...
Cached Medicine News:Health News:Scripps Research scientists uncover previously unknown natural mechanism that controls cocaine use 2Health News:Scripps Research scientists uncover previously unknown natural mechanism that controls cocaine use 3Health News:1 in 4 Californian children have never seen a dentist, study finds 2Health News:Could Hot Weather Affect Results of a Colorectal Cancer Test? 2Health News:Could Hot Weather Affect Results of a Colorectal Cancer Test? 3Health News:Could Hot Weather Affect Results of a Colorectal Cancer Test? 4Health News: Glucosamine Ineffective for Lower Back Pain Linked to Arthritis 2Health News: Glucosamine Ineffective for Lower Back Pain Linked to Arthritis 3Health News:State of the Art Hospital for Rural Kenya Announced by California Foundation 2Health News:State of the Art Hospital for Rural Kenya Announced by California Foundation 3Health News:Social Security Disability Benefits Can Be Crucial to Surviving With Spinal Cord Injury, Allsup Reports 2Health News:Social Security Disability Benefits Can Be Crucial to Surviving With Spinal Cord Injury, Allsup Reports 3Health News:Social Security Disability Benefits Can Be Crucial to Surviving With Spinal Cord Injury, Allsup Reports 4
... Drug Discovery, Biotechnology, Genomic and Proteomic ... Quality Control over Sample Preparation capability ... advanced benchtop ventilated centrifuge accommodates 4x750 ... capacity production throughput. High throughput screening, ...
... A common sight in laboratories ... providing rugged, dependable centrifuge standards for ... laboratories. The Model K's simple, classic ... make it a standard for centrifuge ...
Inquire...
... Use of the Hybridization Oven/Shaker rigidly ... ensuring the stringency of hybridization and ... and reproducible probing of nucleic acids ... Developed for use with radioactive and ...
Medicine Products: